An Observational Study, Called FINEGUST, to Learn More About How People With Chronic Kidney Disease and Type 2 Diabetes Are Treated and How the Introduction of New Treatment Options, Like Finerenone, Impacts Clinical Practice
Clinical trial NCT05526157 · COMPLETED
Trial details
- NCT number
- NCT05526157
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-10-01
- Primary completion
- 2024-09-05
- Enrollment
- 50000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.